| NCT06767514 | Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 | RECRUITING | PHASE3 | 2025-02-27 | 2029-06 | 2028-04 |
| NCT05899608 | Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients | RECRUITING | PHASE3 | 2023-10-26 | 2028-12-31 | 2027-12-31 |
| NCT06396065 | Phase III Study of AK112 for NSCLC Patients | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-05-04 | 2025-12-31 | 2025-12-31 |
| NCT04802837 | Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects | TERMINATED | PHASE3 | 2021-05-19 | 2022-09-28 | 2021-09-17 |
| NCT03595553 | Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | COMPLETED | PHASE3 | 2019-01-28 | 2021-11-17 | 2021-11-17 |
| NCT02858362 | Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) | TERMINATED | PHASE2 | 2016-06 | 2018-09-11 | 2018-04-11 |
| NCT02383511 | Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet | COMPLETED | PHASE1 | 2015-02 | 2015-08 | 2015-08 |
| NCT02784002 | A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) | COMPLETED | PHASE2 | 2014-12 | 2016-08 | 2016-08 |
| NCT02092935 | A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) | COMPLETED | PHASE2 | 2014-04 | 2015-10 | 2015-10 |
| NCT02056808 | A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) | COMPLETED | PHASE1 | 2013-11 | 2014-07 | 2014-05 |